Ferrochelatase
Bacillus subtilis
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein monomer Monomer Protein × 1 PDB declaration: monomeric(1) Consistent with protein copy count | Chain A; UniProt 1–310 | Mutation:Y13M | MG MAGNESIUM ION × 2 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 7.4;298 K;25-30 % PEG 2000, 0.2 M MgCl2, 0.1 M TRIS-HCL, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K | Resolution 1.60 Å R-free 0.232 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 3GOQ | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1AK1 FERROCHELATASE FROM BACILLUS SUBTILIS Deposited 1997-05-28 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
seeded;pH 8.5;CRYSTALS GROW IN 30% PEG 2000, 0.2 M MGCL2 0.1 M TRIS-HCL, PH 8.5. THESE WERE VORTEXED AND USED AS SEEDS FOR LARGE SINGLE CRYSTALS IN: 27% PEG 2000, 0.2 M MGCL2, 0.05% NAN3, 0.1 M TRIS-HCL, PH 8.5, seeded
|
Resolution 1.90 Å R-free 0.243 |
| 1C1H CRYSTAL STRUCTURE OF BACILLUS SUBTILIS FERROCHELATASE IN COMPLEX WITH N-METHYL MESOPORPHYRIN Deposited 1999-07-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Not recorded | MG MAGNESIUM ION × 1 MMP N-METHYLMESOPORPHYRIN × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;PEG 2000, MAGNESIUM CHLORIDE, TRIS-HCL, pH 8.5, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.90 Å R-free 0.231 |
| 1C9E STRUCTURE OF FERROCHELATASE WITH COPPER(II) N-METHYLMESOPORPHYRIN COMPLEX BOUND AT THE ACTIVE SITE Deposited 1999-08-02 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
5–310(306 aa)
|
Not recorded | MG MAGNESIUM ION × 1 MP1 N-METHYLMESOPORPHYRIN CONTAINING COPPER × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;298 K;PEG 2000, magnesium chloride, TRIS, copper sulfate, N-methylmesoporphyrin, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 2.30 Å R-free 0.255 |
| 1DOZ CRYSTAL STRUCTURE OF FERROCHELATASE Deposited 1999-12-22 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–310(309 aa)
|
Not recorded | MG MAGNESIUM ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;298 K;PEG2000, MAGNESIUM CHLORIDE, TRIS, pH 7.4, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K
|
Resolution 1.80 Å R-free 0.216 |
| 1LD3 Crystal Structure of B. subilis ferrochelatase with Zn(2+) bound at the active site. Deposited 2002-04-08 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Not recorded | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;PEG 2000, magnesium chloride, Tris, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.60 Å R-free 0.274 |
| 1N0I Crystal Structure of Ferrochelatase with Cadmium bound at active site Deposited 2002-10-14 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Not recorded | CD CADMIUM ION × 2 CL CHLORIDE ION × 2 MG MAGNESIUM ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.4;298 K;PEG2000, magnesium chloride, tris, pH 7.4, VAPOR DIFFUSION, temperature 298K
|
Resolution 2.00 Å R-free 0.273 |
| 2AC2 Crystal structure of the Tyr13Phe mutant variant of Bacillus subtilis Ferrochelatase with Zn(2+) bound at the active site Deposited 2005-07-18 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–310(309 aa)
|
Mutation:Y13F | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.4;288 K;PEG 2000, magnesium chloride, tris, pH 7.4, VAPOR DIFFUSION, temperature 288K
|
Resolution 2.50 Å R-free 0.257 |
| 2AC4 Crystal structure of the His183Cys mutant variant of Bacillus subtilis Ferrochelatase Deposited 2005-07-18 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–310(309 aa)
|
Mutation:H183C | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.4;298 K;PEG 2000, magnesium chloride, tris, pH 7.4, VAPOR DIFFUSION, temperature 298K
|
Resolution 2.10 Å R-free 0.276 |
| 2H1V Crystal structure of the Lys87Ala mutant variant of Bacillus subtilis ferrochelatase Deposited 2006-05-17 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:K87A | MG MAGNESIUM ION × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.4;288 K;25-30% PEG 2000, 0.2 M magnesium chloride, 0.1 M Tris-HCl, pH 7.4, VAPOR DIFFUSION, temperature 288K
|
Resolution 1.20 Å R-free 0.173 |
| 2H1W Crystal structure of the His183Ala mutant variant of Bacillus subtilis ferrochelatase Deposited 2006-05-17 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:H183A | FE2 FE (II) ION × 1 MG MAGNESIUM ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.4;288 K;25-30 % PEG2000, 0.2 M magnesium chloride, 0.1 M Tris-HCl, pH 7.4, VAPOR DIFFUSION, temperature 288K
|
Resolution 2.60 Å R-free 0.259 |
| 2HK6 Crystal Structure of B. subtilis ferrochelatase with Iron bound at the active site Deposited 2006-07-03 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Not recorded | FE FE (III) ION × 4 MG MAGNESIUM ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;288 K;25% PEG 2000, 0.2 M MgCl2, 0.1 M Tris-HCl , pH 8.0, VAPOR DIFFUSION, temperature 288K
|
Resolution 1.71 Å R-free 0.220 |
| 2Q2N Crystal structure of Bacillus subtilis ferrochelatase in complex with deuteroporphyrin IX 2,4-disulfonic acid dihydrochloride Deposited 2007-05-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–310(309 aa)
|
Not recorded | MG MAGNESIUM ION × 2 H01 PROTOPORPHYRIN IX 2,4-DISULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;298 K;30% PEG 2000, 0.1M Tris/HCl pH 8, 0.2M magnesium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 1.80 Å R-free 0.250 |
| 2Q2O Crystal structure of H183C Bacillus subtilis ferrochelatase in complex with deuteroporphyrin IX 2,4-disulfonic acid dihydrochloride Deposited 2007-05-29 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–310(309 aa)
|
Mutation:H183C | MG MAGNESIUM ION × 1 H01 PROTOPORPHYRIN IX 2,4-DISULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;298 K;30% PEG 2000, 0.1M Tris/HCl pH 8, 0.2M magnesium chloride, 0.1M spermin, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 2.10 Å R-free 0.219 |
| 2Q3J Crystal structure of the His183Ala variant of Bacillus subtilis ferrochelatase in complex with N-Methyl Mesoporphyrin Deposited 2007-05-30 | Different construct Different mutation/modification Different ligand/ion Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–310(309 aa)
|
Mutation:H183A | MG MAGNESIUM ION × 1 H02 N-METHYL PROTOPORPHYRIN IX 2,4-DISULFONIC ACID × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;298 K;25-30 % PEG 2000, 0.2 M MgCl2, 0.1 M TRIS-HCL, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.39 Å R-free 0.228 |
| 3M4Z Crystal Structure of B. subtilis ferrochelatase with Cobalt bound at the active site Deposited 2010-03-12 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
2–310(309 aa)
|
Not recorded | CO COBALT (II) ION × 1 MG MAGNESIUM ION × 3 CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;25% PEG 2000, 0.2M MgCl2, 0.1M Tris-HCl, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.94 Å R-free 0.199 |
| 9KTA Bacillus subtilis CpfC (HemH) Y13C variant Deposited 2024-12-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:Y13C | MG MAGNESIUM ION × 5 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;0.1M MgCl2, 0.05M Bis-Tris, 12.5%(w/v) PEG3350
|
Resolution 1.00 Å R-free 0.190 |
| 9KTB Bacillus subtilis CpfC (HemH) Y13C variant modified with bromobimane Deposited 2024-12-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:Y13C | 9UM 3-(bromomethyl)-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione × 1 MG MAGNESIUM ION × 5 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.2M MgCl2, 0.1M Bis-Tris, 25%(w/v) PEG3000
|
Resolution 1.13 Å R-free 0.188 |
| 9KTC Mn(II)-bound CpfC (HemH) Y13C variant modified with bromobimane Deposited 2024-12-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:Y13C | 9UM 3-(bromomethyl)-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione × 1 MG MAGNESIUM ION × 3 MN MANGANESE (II) ION × 3 CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.2M MgCl2, 0.1M Bis-Tris, 30%(w/v) PEG3350, 4.5 mM MnCl2
|
Resolution 1.50 Å R-free 0.246 |
| 9KTD Fe(II)-bound CpfC (HemH) Y13C variant modified with bromobimane Deposited 2024-12-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:Y13C | MG MAGNESIUM ION × 2 CL CHLORIDE ION × 5 9UM 3-(bromomethyl)-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione × 1 FE2 FE (II) ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.2M MgCl2, 0.1M Bis-Tris, 30%(w/v) PEG3350, 4.5 mM Fe(NH4)2(SO4)2
|
Resolution 1.38 Å R-free 0.207 |
| 9KTE Co(II)-bound CpfC (HemH) Y13C variant modified with bromobimane Deposited 2024-12-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:Y13C | CO COBALT (II) ION × 6 MG MAGNESIUM ION × 3 CL CHLORIDE ION × 3 9UM 3-(bromomethyl)-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.2M MgCl2, 0.1M Bis-Tris, 25%(w/v) PEG4000
|
Resolution 1.46 Å R-free 0.196 |
| 9KTF Ni(II)-bound Bacillus subtilis CpfC (HemH) Y13C variant modified with bromobimane Deposited 2024-12-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:Y13C | 9UM 3-(bromomethyl)-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione × 1 MG MAGNESIUM ION × 3 NI NICKEL (II) ION × 2 CL CHLORIDE ION × 5 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.2M MgCl2, 0.1M Bis-Tris, 25%(w/v) PEG4000, 4.5 mM NiCl2
|
Resolution 1.44 Å R-free 0.192 |
| 9KTG Cu(II)-bound CpfC (HemH) Y13C variant modified with bromobimane Deposited 2024-12-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:Y13C | 9UM 3-(bromomethyl)-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione × 1 CU COPPER (II) ION × 5 MG MAGNESIUM ION × 3 CL CHLORIDE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.2M MgCl2, 0.1M Bis-Tris, 30%(w/v) PEG3350, 4.5 mM CuCl2
|
Resolution 1.44 Å R-free 0.197 |
| 9KTH Zn(II)-bound CpfC (HemH) Y13C variant modified with bromobimane Deposited 2024-12-02 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–310(310 aa)
|
Mutation:Y13C | ZN ZINC ION × 6 MG MAGNESIUM ION × 3 9UM 3-(bromomethyl)-2,5,6-trimethyl-1H,7H-pyrazolo[1,2-a]pyrazole-1,7-dione × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;293 K;0.2M MgCl2, 0.1M Bis-Tris, 30%(w/v) PEG3350
|
Resolution 1.90 Å R-free 0.247 |
23 other PDB entries and 23 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | HEMH_BACSU |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–310; UniProt 1–310 |